Our AI-powered technology provides accessible
and immediate screening, revolutionizing how we approach
identification of conditions like obstructive sleep apnea.
Join the growing network of organizations transforming OSA identification and care.
Organizations using Soliish to identify high-intent patients
Reduction in manual administrative workloads across the entire patient onboarding process
Increase in qualified patient referrals for treatment providers
Obstructive Sleep Apnea affects millions worldwide, yet most cases remain undiagnosed,
leading to significant health and economic impacts.
936+
People affected globally, with 80% remaining undiagnosed
$150B+
Annual economic impact from lost productivity and healthcare costs
2-5 Years
Average time from symptom onset to clinical diagnosis
40%
Of OSA patients develop serious comorbidities before diagnosis
For businesses, this represents missed opportunities to engage high-intent patients early and improve outcomes while reducing costs.
How we helpOur cutting-edge face scan technology uses artificial intelligence to analyze your facial structure and identify
potential risks for sleep apnea. Here's a breakdown of the science that makes it all possible:
Connect with our team to learn how Soliish can help you or your organization
Find answers to frequently asked questions about our technology and services.
Our technology has been clinically validated with accuracy comparable to traditional OSA screening tools. The AI-powered analysis detects subtle facial features and patterns associated with OSA risk factors, helping identify individuals who may benefit from further evaluation.
Yes. All data is stored in secure, HIPAA-compliant U.S.-based servers. Information is encrypted and used only for screening and education purposes—not for marketing or resale. For international customers, Soliish aligns with GDPR and local data-protection requirements to ensure full privacy and compliance.
Once the screening is complete, users receive an OSA risk score classified as low, moderate, or high. Those identified at risk can be directed to a licensed provider or home sleep test for diagnostic confirmation and care planning. The goal is to simplify the path from awareness to diagnosis and treatment.
No. The Soliish scan is a screening tool, not a diagnostic device. It identifies individuals who may be at risk for obstructive sleep apnea (OSA) and guides them toward appropriate diagnostic testing such as a home sleep test or polysomnography.
Soliish supports API-based integration for seamless data flow and workflow alignment. It can operate as a standalone web experience or be embedded directly into existing EHR or patient-engagement systems for effortless clinician and patient access.
Soliish improves top-of-funnel engagement and reduces diagnostic delays by quickly identifying at-risk patients. Organizations using the platform report higher screening volumes, faster patientactivation, and better utilization of downstream clinical services—helping improve both patient outcomes and operational efficiency.
Yes. Soliish offers flexible branding options—from co-branded experiences to fully white-labeled deployments with your domain and integrated workflows. This allows you to maintain brand consistency while delivering a seamless patient experience.
Our team provides end-to-end onboarding, including technical setup, integration guidance, staff training, and performance tracking. We ensure smooth deployment, monitor engagement metrics, and provide ongoing support to help partners maximize results.
